Gene test could predict heart attack and stroke risk

NCT ID NCT06855394

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examines whether a common gene variation (CYP2C19) influences the long-term risk of serious heart and blood vessel events, such as heart attacks, strokes, and limb problems, in people with vascular disease. Researchers will analyze genetic and health data from 13,000 patients at the University of Florida. The goal is to better understand how genetics affect treatment outcomes, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS OF ARTERIES OF THE EXTREMITIES, UNSPECIFIED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UF Health

    Gainesville, Florida, 32608, United States

  • UF Health

    Jacksonville, Florida, 32209, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.